PATENT CLAIM ANALYSIS

Application Number: 16123175
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "495000"]

Abstract:
A composition for use in the treatment of a condition or disorder related to mucosal barrier dysfunction in the gut, the composition comprising activated carbon. The condition may be, for example, pouchitis or proctitis.

Claim (Index 19):
A composition according to  claim 1 ,  8 ,  9 ,  10 ,  11 ,  12 ,  13 ,  14 ,  15 ,  16 ,  17  or  18  wherein the second layer is selected from Hypromellose-Acetate-Succinate, cellulose acetate trimellitate (CAT), cellulose acetate phthalate (CAP), anionic copolymers based on methylacrylate, methylmethacrylate and methacrylic acid, hydroxypropyl methylcellulose phthalate (HPMCP), hydroxypropylmethylcellulose acetate succinate (HPMCAS), methacrylic acid and ethyl acrylate copolymers, methacrylic acid and ethyl acrylate copolymers, methacrylic acid and methyl methacrylate copolymers (1:1 ratio), methacrylic acid and methyl methacrylate copolymers (1:2 ratio), Polyvinyl acetate phthalate (PVAP) and Shellac resins.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 1.34483
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14779412', '14429806', '14348379', '15691539', '10569863']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7326066738148724
- 35 USC 102 Novelty (BERT): 0.5697725004667885
- Combined Prediction Score: 0.7163232564800641
- Mean Citation Score: 259.428634
- Max Citation Score: 450.58203
- Similarity Product: 390.4963456895703

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test